LPS Biosolutions A/S

Egen beskrivelse på virk.dk

Key activities The Companiy’s key activities comprises development, production and sale of products and licenses within food ingredients and biotechnology. We have developed our unique protein capture technology, ChimerAds, a disruptive innovation in the functional protein ingredient market, which enable players in the food, and biosolutions industries to manufacture value-added protein ingredients at industrial scale. The ChimerAds technology is developed with a strong focus on sustainability and circular economy, and we have a strong IP position, combined with a highly experienced team with a strong track record. Development in the year In 2025, the Company focused on development of their technology and patenting hereof, combined with sales activities towards industrial customers. Due to a long lead time from commercial agreement to revenue, the operating result for 2026 is negative. The Company has signed several commercial agreements with customers and expect an improved result in 2026. There has not been any single event during the financial year that needs mentioning in this Management’s review.